Clive Wilson PhD

---

Dr. Clive Wilson is OTI Chief Scientific Officer (CSO) and SAB co-chair.   He is the J. P. Todd Professor of Pharmaceutics at Strathclyde University (United Kingdom).  Dr. Wilson serves on the European Union Federation of Pharmaceutical Sciences teaching and overseas liaison committee.  Dr. Wilson has received many awards and prizes for his outstanding industrial collaborations in the area of drug delivery and pharmacology, including GSK International Achievement Award.  Prior to joining OTI,  Dr. Wilson served as the CSO of Revana Therapeutics. He played a pivotal role in building Revana's sustained release ocular drug delivery technology platform.

He obtained his  Bachelor degree in Applied Biology at The Hatfield Polytechnic (now University of Hertfordshire) with an intercalated year in Aviation Medicine at RAF Farnborough earning a first-class honors in 1970.  He completed his PhD in drug metabolism at the University of Surrey in drug metabolism under the mentorship of  the late Professor D V Parkes.